Cargando…
Toward New Therapeutics for Skin and Soft Tissue Infections: Propargyl-Linked Antifolates Are Potent Inhibitors of MRSA and Streptococcus pyogenes
Hospital- and community-acquired, complicated skin and soft tissue infections, often attributed to Staphylococcus aureus and Streptococcus pyogenes, present a significant health burden that is associated with increased health care costs and mortality. As these two species are difficult to discern on...
Autores principales: | Viswanathan, Kishore, Frey, Kathleen M., Scocchera, Eric W., Martin, Brooke D., Swain III, P. Whitney, Alverson, Jeremy B., Priestley, Nigel D., Anderson, Amy C., Wright, Dennis L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274548/ https://www.ncbi.nlm.nih.gov/pubmed/22347365 http://dx.doi.org/10.1371/journal.pone.0029434 |
Ejemplares similares
-
Propargyl-Linked Antifolates
are Dual Inhibitors of Candida albicans and Candida glabrata
por: G-Dayanandan, Narendran, et al.
Publicado: (2014) -
Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis
por: Hajian, Behnoush, et al.
Publicado: (2016) -
Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates
por: Lombardo, M.N., et al.
Publicado: (2019) -
Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates
por: Cammarata, Michael, et al.
Publicado: (2017) -
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival
por: Guijarro, Maria V., et al.
Publicado: (2023)